![]() |
市場調查報告書
商品編碼
1394210
全球低聚半乳糖 (GOS) 市場評估:依形式、應用、最終用途、地區、機會、預測(2016-2030 年)Galacto-oligosaccharides Market Assessment, By Form, By Application, By End-use, By Region, Opportunities and Forecast, 2016-2030F |
全球低聚半乳糖 (GOS) 市場規模預計將從 2022 年的 50.94 千噸增至 2030 年的 78.18 千噸,在 2023-2030 年預測期間複合年增長率為 5.5%。 市場受到促進其成長和繁榮的幾個關鍵驅動因素的影響。 主要驅動因素之一是人們對腸道健康重要性的認識不斷提高。 消費者現在越來越意識到健康的腸道菌叢如何影響他們的整體健康,導致對 GOS 等益生元成分的高需求。
功能性食品和飲料的日益普及也導致消費者尋求除基本營養之外還能提供健康益處的產品,而 GOS 越來越多地用於這些功能性產品中。這是因為 此外,由於 GOS 與母乳寡糖 (HMO) 相似,因此在嬰兒配方奶粉中使用 GOS 正在推動嬰兒營養領域的需求。
此外,功能性飲料(包括益生菌和益生元飲料)的開發正在擴大 GOS 的使用。 這些飲料因其改善消化健康的潛力而越來越受歡迎。 總而言之,研究和臨床研究正在推動 GOS 市場的發展,因為正在進行的關於 GOS 健康益處的研究和臨床研究的積極結果正在推動該成分的聲譽和需求不斷增長,並發揮著重要作用。
隨著人們對寵物健康和營養重要性的認識不斷增強,低聚半乳糖 (GOS) 在寵物飼料中的使用越來越受到關注。 GOS專注於促進寵物消化系統的健康,並為您的寵物提供多種益處,包括支持寵物的腸道菌叢、幫助消化以及減少胃腸道疾病的發生率。 此外,GOS 已顯示出增強寵物免疫系統、增強抗病能力和減輕寵物過敏反應的潛力,使其成為治療常見寵物過敏的寶貴成分。我們已經確立了自己的地位。
例如,Nestle Purina PetCare Co.投資 1.82 億美元擴建其位於美國維吉尼亞州威廉王縣的寵物護理產品製造工廠。 擴大生產和對寵物飼料的強勁需求正在推動全球低聚半乳糖(GOS)的發展。
低聚半乳糖 (GOS) 在營養保健品產業中發揮著至關重要的作用,並因其潛在的健康益處而受到廣泛吹捧,特別是在支持腸道健康方面。 人們對消化健康的興趣日益濃厚,推動了營養保健品領域對 GOS 的龐大需求。 此外,營養保健品產業的興起也伴隨著功能性飲料的發展。 這包括一系列產品,例如益生菌和益生元飲料和食品,旨在透過改善腸道微生物平衡來改善整體健康。
例如,2023 年7 月,FHIRST Living Soda 進入飲料市場,推出了一款開創性的全天然無糖飲料,該飲料採用益生菌和益生元的獨特混合物來支持腸道健康。我證明了這一點。 隨著世界各地功能性食品的不斷推出,對低聚半乳糖(GOS)的需求不斷增加。
GOS 一直是研究的重點,重點是其緩解胃腸道疾病相關症狀的潛力,包括腸躁症 (IBS) 和發炎性腸道疾病 (IBD) 等疾病。 GOS 促進有益腸道細菌的生長,有望有助於促進腸道健康並減少相關症狀。 除了解決胃腸道疾病外,它還用於治療腹瀉。 因此,它是某些旨在緩解腹瀉的藥物(例如口服補液鹽)中的特色成分,特別注重對嬰兒和幼兒的有效性。
例如,2023 年第一季度,Johnson & Johnson公佈了驕人業績,美國銷售額增長約 10%,總計 125.2 億美元。 藥品銷售的激增預計將導致 GOS 需求的增加。
本報告研究分析了全球低聚半乳糖(GOS)市場,提供市場規模和預測、市場動態、主要參與者的現狀和前景等。
Global galacto-oligosaccharides market size was recorded at 50.94 kilotons in 2022, which is expected to grow to 78.18 kilotons in 2030 with a CAGR of 5.5%, during the forecast period between 2023 and 2030. The galacto-oligosaccharides market is influenced by several key drivers that have contributed to its growth and prominence. One of the primary drivers is the increasing awareness of the importance of gut health. Consumers are now more conscious of how a healthy gut microbiome can impact overall well-being, which has led to a higher demand for prebiotic ingredients, like GOS.
The rising popularity of functional foods and beverages is another significant driver as consumers seek products that offer health benefits beyond basic nutrition, and GOS is often used in these functional items. Additionally, the use of GOS in infant formula due to its similarity to human milk oligosaccharides (HMOs) has propelled demand in the infant nutrition segment.
Moreover, the development of functional beverages, including probiotic and prebiotic drinks, has expanded the use of GOS. These beverages have gained popularity for their potential to enhance digestive health. Conclusively, Research and clinical studies have played a significant role in advancing the GOS market as ongoing research into the health benefits of GOS and positive results from clinical studies have contributed to the growing reputation and demand for this ingredient.
The utilization of Galacto-oligosaccharides (GOS) in pet feed is gaining prominence, driven by the growing recognition of the significance of pet health and nutrition. GOS offers a range of benefits for pets, with a primary focus on enhancing their digestive health, and supports the pet's gut microbiome, aids in digestion, and diminishing the occurrence of gastrointestinal issues. Moreover, GOS has demonstrated its potential in fortifying the immune system of pets, bolstering their resistance to diseases and serve to mitigate allergic reactions in pets, thus establishing itself as a valuable ingredient for the management of common pet allergies.
For instance, Nestle Purina PetCare Co. allocated an investment of USD 182 million to expand its manufacturing facility for pet care products in King William County, Virginia, the United States. Expansion of manufacturing and strong demand for pet feed to strengthen the Galacto-oligosaccharides globally.
Galacto-oligosaccharides play a pivotal role in the dietary supplements industry, where it is widely promoted for its potential health benefits, particularly in supporting gut health. The increasing focus on digestive well-being has driven significant demand for GOS within the dietary supplements sector. Moreover, the surge in the dietary supplements industry has been accompanied by the development of functional beverages. It includes a range of products like probiotic and prebiotic drinks and foods that aim to enhance overall health through improved gut microbiome balance.
For instance, during July 2023, FHIRST Living Soda entered the beverage market, marking the pioneering all-natural, sugar-free drink that uniquely blends probiotics and prebiotics to support gut health. The rise in launches of functional foods across the globe increases the demand for galacto-oligosaccharides.
GOS has been the subject of research focused on its potential to mitigate symptoms associated with gastrointestinal disorders, including conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). GOS fosters the proliferation of beneficial gut bacteria and has shown promise and helps in enhancing gut health and diminishing associated symptoms. In addition to addressing gastrointestinal disorders, it is used for managing diarrhea. Therefore, it is a featured ingredient in specific pharmaceutical products, such as oral rehydration solutions, designed to alleviate diarrhea, with a particular focus on its efficacy in infants and young children.
For instance, during Q1 of 2023, Johnson & Johnson reported impressive results in their sales experiencing a robust upswing of nearly 10 percent in the United States, reaching a total of USD 12.52 billion. The upsurge in sales of pharmaceuticals is expected to contribute to rising demand for GOS.
The galacto-oligosaccharides market experienced significant disruption due to the outbreak of COVID-19. Although the pandemic had a relatively milder impact on the food and beverage industry compared to other sectors, it severely affected the industry's global supply chain, constraining its growth potential. The shift in consumer behavior during this time had a detrimental effect on purchasing patterns, resulting in several challenges, including operational halts, hindrances to business expansion, and suspended activities. However, on the other hand, the lockdown heightened demand for GOS in few applications as the need for pet feed and prebiotic drinks increased during the pandemic.
A huge percentage of the population of people across the globe is lactose intolerant, which is a major restrain to the market. However, the development of plant-based GOS will witness a consumption increase within this population.
The ongoing research of GOS in pharmaceuticals along with growing awareness of gut health will improve the demand for galacto-oligosaccharides market globally.
Key players in the galacto-oligosaccharide market are actively involved in the creation of innovative products, primarily intended to function as dietary supplements. This strategic initiative is coordinated with the increasing worldwide need for nutritional supplements and the industry's adaptability to changing consumer preferences in this regard. It underscores a dedication in addressing the rising market requirements for health-oriented products, emphasizing a pivotal role of galacto-oligosaccharide in modern dietary solutions.
For instance, in August 2022, FrieslandCampina Ingredients created a specialized prebiotic with the aim of spurring innovation in the expanding market for gut health supplements. Featuring an exceptionally high galacto-oligosaccharide content of more than 90%, Biotis GOS-OP High Purity stands as the company's most refined prebiotic ingredient.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.